tiprankstipranks
Finch Therapeutics Group (FNCHQ)
OTHER OTC:FNCHQ
US Market
FNCHQ
Finch Therapeutics Group
RESEARCH TOOLSreports
Want to see FNCHQ full AI Analyst Report?

Finch Therapeutics Group (FNCHQ) Income Statement

63 Followers

Finch Therapeutics Group Income Statement

Last quarter (Q2 2024), Finch Therapeutics Group's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Finch Therapeutics Group's net income was $-4.83M. See Finch Therapeutics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Mar 22Dec 20Dec 19
Total Revenue
$ 107.00K$ 861.00K$ 18.53M$ 7.72M$ 10.15M
Gross Profit
$ -1.41M$ -4.65M$ -38.75M$ -25.43M$ 9.84M
Operating Expenses
$ 32.59M$ 90.47M$ 78.52M$ 47.16M$ 30.98M
Depreciation and Amortization
$ 1.52M$ 5.51M$ 2.30M$ 790.00K$ 482.00K
EBITDA
$ -32.48M$ -82.69M$ -57.68M$ -38.65M$ -20.66M
Operating Income
$ -34.00M$ -95.12M$ -59.98M$ -39.44M$ -21.14M
Other Income/Expenses
$ -44.21M$ -19.53M$ 1.82M$ 95.00K$ 388.00K
Pretax Income
$ -78.22M$ -114.65M$ -58.16M$ -39.34M$ -20.75M
Net Income
$ -74.75M$ -114.65M$ -58.16M$ -39.25M$ -20.75M
Per Share Metrics
Basic EPS
$ -46.59$ -72.12$ -36.72$ -24.39$ -12.68
Diluted EPS
$ -46.59$ -72.12$ -36.72$ -24.39$ -12.68
Weighted Average Shares Outstanding
 1.60M 1.59M 1.58M 1.61M 1.61M
Weighted Average Shares Outstanding (Diluted)
 1.60M 1.59M 1.58M 1.61M 1.61M
Currency in USD

Finch Therapeutics Group Earnings and Revenue History